Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational Study
NCT07016282 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-09-02
Summary
This is a no-profit, retrospective observational study involving real-world data (RWD), retrieved from ADPKD-related electronic health records stored at Mario Negri Institute IRCCS. RWD will be used to generate simulated and synthetic datasets, using AI tools. RWD and generated data (GD) will be used to conduct three virtual RCTs, which main outcome is change in Total Kidney Volume (TKV). Statistical tests will be performed to assess quality and privacy preservation of GD compared with RWD. GD will be also evaluated in exploratory sample size estimations.
Conditions
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Sponsors & Collaborators
-
Mario Negri Institute for Pharmacological Research
lead OTHER
Principal Investigators
-
Giuseppe Remuzzi, M.D. · Istituto Di Ricerche Farmacologiche Mario Negri
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-12
- Primary Completion
- 2027-06-30
- Completion
- 2027-06-30
Countries
- Italy
- Sweden
Study Locations
More Related Trials
-
Imaging Assessments of ARPKD Kidney Disease Progression
NCT07201025 ·Status: RECRUITING
-
ADPKD Cohort Study
NCT02084849 ·Status: COMPLETED
-
Efficacy of Tolvaptan on ADPKD Patients
NCT02729662 ·Status: UNKNOWN ·Phase: NA
-
Set-up of a Platform for Personalized Diagnosis of Rare Kidney Diseases (NIKE)
NCT06325072 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ADPKD Alterations in Hepatic Transporter Function
NCT03717883 ·Status: COMPLETED
-
Artificial Intelligence-based Techniques to Characterize KIdney Microstructure on Histological ImagEs
NCT06690190 ·Status: ACTIVE_NOT_RECRUITING
-
The German ADPKD Tolvaptan Treatment Registry
NCT02497521 ·Status: RECRUITING
-
Prospective Validation of AKI Prediction
NCT06804200 ·Status: RECRUITING
-
Kidney AI-enabled Care Transformation
NCT05056909 ·Status: WITHDRAWN ·Phase: NA
-
Kidney Precision Medicine Project
NCT04334707 ·Status: RECRUITING
-
New Analytic Tools for aHUS and C3G Diagnosis
NCT05985122 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Big Data Approach to Predict NEOnatal Acute Kidney Injury in Newborns expoSed to nephroTOxic Drugs (NeoAKI STOP)
NCT05851222 ·Status: UNKNOWN
-
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease
NCT06085807 ·Status: COMPLETED
-
The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
NCT02187432 ·Status: UNKNOWN
-
Early PKD Observational Cohort Study
NCT02936791 ·Status: RECRUITING
-
Somatosensory Phenotyping of ADPKD
NCT06970028 ·Status: RECRUITING
-
Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD
NCT06496542 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKD
NCT03493802 ·Status: COMPLETED
-
Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
NCT02776241 ·Status: COMPLETED ·Phase: NA
-
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
NCT05468203 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of Water Drinking on PKD Progression.
NCT01348035 ·Status: COMPLETED
-
Precision Medicine Approach to Unravel the Risk Factors for Renal, Cardiovascular, Ophthalmologic, Neurologic and Hepatic Complications of Metabolic Disorders
NCT05307172 ·Status: WITHDRAWN
-
Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)
NCT00327860 ·Status: RECRUITING
-
Study to Evaluate the Use of RenalGuard to Protect Patients at High Risk of AKI
NCT02793661 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"
NCT06338631 ·Status: RECRUITING